Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Urol Oncol. 2017 May 12;35(7):473–491. doi: 10.1016/j.urolonc.2017.04.014

Figure 6.

Figure 6

Demonstration of viable tumor volume (VTV) where a metastatic urothelial carcinoma lesion became less dense (less IV contrast enhancement) visually; however, the left shift of the histogram objectively represents likely tumor necrosis from an antiangiogenic treatment.